The global Viral Vaccines market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Viral Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Viral Vaccines.

Report Scope

The Viral Vaccines market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Viral Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Viral Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Viral Vaccines Market Report

Report Metric	Details
Report Name	Viral Vaccines Market
CAGR	5%
Segment by Type	Attenuated Vaccine Inactivated Vaccine
Segment by Application	Hospital Pharmaceutical Factory Research Institute Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	GSK, Merck, Novartis, Pfizer, Sanofi, Bayer, Zoetis, AstraZeneca, Johnson, CSL
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Viral Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Viral Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Viral Vaccines Market report?

Ans: The main players in the Viral Vaccines Market are GSK, Merck, Novartis, Pfizer, Sanofi, Bayer, Zoetis, AstraZeneca, Johnson, CSL

What are the Application segmentation covered in the Viral Vaccines Market report?

Ans: The Applications covered in the Viral Vaccines Market report are Hospital, Pharmaceutical Factory, Research Institute, Others

What are the Type segmentation covered in the Viral Vaccines Market report?

Ans: The Types covered in the Viral Vaccines Market report are Attenuated Vaccine, Inactivated Vaccine

1 Viral Vaccines Market Overview

1.1 Product Overview and Scope of Viral Vaccines

1.2 Viral Vaccines Segment by Type

1.2.1 Global Viral Vaccines Market Value Comparison by Type (2024-2030)

1.2.2 Attenuated Vaccine

1.2.3 Inactivated Vaccine

1.3 Viral Vaccines Segment by Application

1.3.1 Global Viral Vaccines Market Value by Application: (2024-2030)

1.3.2 Hospital

1.3.3 Pharmaceutical Factory

1.3.4 Research Institute

1.3.5 Others

1.4 Global Viral Vaccines Market Size Estimates and Forecasts

1.4.1 Global Viral Vaccines Revenue 2019-2030

1.4.2 Global Viral Vaccines Sales 2019-2030

1.4.3 Global Viral Vaccines Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Viral Vaccines Market Competition by Manufacturers

2.1 Global Viral Vaccines Sales Market Share by Manufacturers (2019-2024)

2.2 Global Viral Vaccines Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Viral Vaccines Average Price by Manufacturers (2019-2024)

2.4 Global Viral Vaccines Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Viral Vaccines, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Viral Vaccines, Product Type & Application

2.7 Viral Vaccines Market Competitive Situation and Trends

2.7.1 Viral Vaccines Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Viral Vaccines Players Market Share by Revenue

2.7.3 Global Viral Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Viral Vaccines Retrospective Market Scenario by Region

3.1 Global Viral Vaccines Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Viral Vaccines Global Viral Vaccines Sales by Region: 2019-2030

3.2.1 Global Viral Vaccines Sales by Region: 2019-2024

3.2.2 Global Viral Vaccines Sales by Region: 2025-2030

3.3 Global Viral Vaccines Global Viral Vaccines Revenue by Region: 2019-2030

3.3.1 Global Viral Vaccines Revenue by Region: 2019-2024

3.3.2 Global Viral Vaccines Revenue by Region: 2025-2030

3.4 North America Viral Vaccines Market Facts & Figures by Country

3.4.1 North America Viral Vaccines Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Viral Vaccines Sales by Country (2019-2030)

3.4.3 North America Viral Vaccines Revenue by Country (2019-2030)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Viral Vaccines Market Facts & Figures by Country

3.5.1 Europe Viral Vaccines Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Viral Vaccines Sales by Country (2019-2030)

3.5.3 Europe Viral Vaccines Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Viral Vaccines Market Facts & Figures by Country

3.6.1 Asia Pacific Viral Vaccines Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Viral Vaccines Sales by Country (2019-2030)

3.6.3 Asia Pacific Viral Vaccines Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Viral Vaccines Market Facts & Figures by Country

3.7.1 Latin America Viral Vaccines Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Viral Vaccines Sales by Country (2019-2030)

3.7.3 Latin America Viral Vaccines Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Viral Vaccines Market Facts & Figures by Country

3.8.1 Middle East and Africa Viral Vaccines Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Viral Vaccines Sales by Country (2019-2030)

3.8.3 Middle East and Africa Viral Vaccines Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Viral Vaccines Sales by Type (2019-2030)

4.1.1 Global Viral Vaccines Sales by Type (2019-2024)

4.1.2 Global Viral Vaccines Sales by Type (2025-2030)

4.1.3 Global Viral Vaccines Sales Market Share by Type (2019-2030)

4.2 Global Viral Vaccines Revenue by Type (2019-2030)

4.2.1 Global Viral Vaccines Revenue by Type (2019-2024)

4.2.2 Global Viral Vaccines Revenue by Type (2025-2030)

4.2.3 Global Viral Vaccines Revenue Market Share by Type (2019-2030)

4.3 Global Viral Vaccines Price by Type (2019-2030)

5 Segment by Application

5.1 Global Viral Vaccines Sales by Application (2019-2030)

5.1.1 Global Viral Vaccines Sales by Application (2019-2024)

5.1.2 Global Viral Vaccines Sales by Application (2025-2030)

5.1.3 Global Viral Vaccines Sales Market Share by Application (2019-2030)

5.2 Global Viral Vaccines Revenue by Application (2019-2030)

5.2.1 Global Viral Vaccines Revenue by Application (2019-2024)

5.2.2 Global Viral Vaccines Revenue by Application (2025-2030)

5.2.3 Global Viral Vaccines Revenue Market Share by Application (2019-2030)

5.3 Global Viral Vaccines Price by Application (2019-2030)

6 Key Companies Profiled

6.1 GSK

6.1.1 GSK Corporation Information

6.1.2 GSK Description and Business Overview

6.1.3 GSK Viral Vaccines Sales, Revenue and Gross Margin (2019-2024)

6.1.4 GSK Viral Vaccines Product Portfolio

6.1.5 GSK Recent Developments/Updates

6.2 Merck

6.2.1 Merck Corporation Information

6.2.2 Merck Description and Business Overview

6.2.3 Merck Viral Vaccines Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Merck Viral Vaccines Product Portfolio

6.2.5 Merck Recent Developments/Updates

6.3 Novartis

6.3.1 Novartis Corporation Information

6.3.2 Novartis Description and Business Overview

6.3.3 Novartis Viral Vaccines Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Novartis Viral Vaccines Product Portfolio

6.3.5 Novartis Recent Developments/Updates

6.4 Pfizer

6.4.1 Pfizer Corporation Information

6.4.2 Pfizer Description and Business Overview

6.4.3 Pfizer Viral Vaccines Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Pfizer Viral Vaccines Product Portfolio

6.4.5 Pfizer Recent Developments/Updates

6.5 Sanofi

6.5.1 Sanofi Corporation Information

6.5.2 Sanofi Description and Business Overview

6.5.3 Sanofi Viral Vaccines Sales, Revenue and Gross Margin (2019-2024)

6.5.4 Sanofi Viral Vaccines Product Portfolio

6.5.5 Sanofi Recent Developments/Updates

6.6 Bayer

6.6.1 Bayer Corporation Information

6.6.2 Bayer Description and Business Overview

6.6.3 Bayer Viral Vaccines Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Bayer Viral Vaccines Product Portfolio

6.6.5 Bayer Recent Developments/Updates

6.7 Zoetis

6.6.1 Zoetis Corporation Information

6.6.2 Zoetis Description and Business Overview

6.6.3 Zoetis Viral Vaccines Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Zoetis Viral Vaccines Product Portfolio

6.7.5 Zoetis Recent Developments/Updates

6.8 AstraZeneca

6.8.1 AstraZeneca Corporation Information

6.8.2 AstraZeneca Description and Business Overview

6.8.3 AstraZeneca Viral Vaccines Sales, Revenue and Gross Margin (2019-2024)

6.8.4 AstraZeneca Viral Vaccines Product Portfolio

6.8.5 AstraZeneca Recent Developments/Updates

6.9 Johnson

6.9.1 Johnson Corporation Information

6.9.2 Johnson Description and Business Overview

6.9.3 Johnson Viral Vaccines Sales, Revenue and Gross Margin (2019-2024)

6.9.4 Johnson Viral Vaccines Product Portfolio

6.9.5 Johnson Recent Developments/Updates

6.10 CSL

6.10.1 CSL Corporation Information

6.10.2 CSL Description and Business Overview

6.10.3 CSL Viral Vaccines Sales, Revenue and Gross Margin (2019-2024)

6.10.4 CSL Viral Vaccines Product Portfolio

6.10.5 CSL Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Viral Vaccines Industry Chain Analysis

7.2 Viral Vaccines Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Viral Vaccines Production Mode & Process

7.4 Viral Vaccines Sales and Marketing

7.4.1 Viral Vaccines Sales Channels

7.4.2 Viral Vaccines Distributors

7.5 Viral Vaccines Customers

8 Viral Vaccines Market Dynamics

8.1 Viral Vaccines Industry Trends

8.2 Viral Vaccines Market Drivers

8.3 Viral Vaccines Market Challenges

8.4 Viral Vaccines Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Global Viral Vaccines Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Viral Vaccines Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global Viral Vaccines Market Competitive Situation by Manufacturers in 2023

Table 4. Global Viral Vaccines Sales (K MT) of Key Manufacturers (2019-2024)

Table 5. Global Viral Vaccines Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Viral Vaccines Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Viral Vaccines Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Viral Vaccines Average Price (USD/MT) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Viral Vaccines, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Viral Vaccines, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Viral Vaccines, Product Type & Application

Table 12. Global Key Manufacturers of Viral Vaccines, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Viral Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Vaccines as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Viral Vaccines Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Viral Vaccines Sales by Region (2019-2024) & (K MT)

Table 18. Global Viral Vaccines Sales Market Share by Region (2019-2024)

Table 19. Global Viral Vaccines Sales by Region (2025-2030) & (K MT)

Table 20. Global Viral Vaccines Sales Market Share by Region (2025-2030)

Table 21. Global Viral Vaccines Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Viral Vaccines Revenue Market Share by Region (2019-2024)

Table 23. Global Viral Vaccines Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Viral Vaccines Revenue Market Share by Region (2025-2030)

Table 25. North America Viral Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Viral Vaccines Sales by Country (2019-2024) & (K MT)

Table 27. North America Viral Vaccines Sales by Country (2025-2030) & (K MT)

Table 28. North America Viral Vaccines Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Viral Vaccines Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Viral Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Viral Vaccines Sales by Country (2019-2024) & (K MT)

Table 32. Europe Viral Vaccines Sales by Country (2025-2030) & (K MT)

Table 33. Europe Viral Vaccines Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Viral Vaccines Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Viral Vaccines Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Viral Vaccines Sales by Region (2019-2024) & (K MT)

Table 37. Asia Pacific Viral Vaccines Sales by Region (2025-2030) & (K MT)

Table 38. Asia Pacific Viral Vaccines Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Viral Vaccines Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Viral Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Viral Vaccines Sales by Country (2019-2024) & (K MT)

Table 42. Latin America Viral Vaccines Sales by Country (2025-2030) & (K MT)

Table 43. Latin America Viral Vaccines Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Viral Vaccines Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Viral Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa Viral Vaccines Sales by Country (2019-2024) & (K MT)

Table 47. Middle East & Africa Viral Vaccines Sales by Country (2025-2030) & (K MT)

Table 48. Middle East & Africa Viral Vaccines Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Viral Vaccines Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Viral Vaccines Sales (K MT) by Type (2019-2024)

Table 51. Global Viral Vaccines Sales (K MT) by Type (2025-2030)

Table 52. Global Viral Vaccines Sales Market Share by Type (2019-2024)

Table 53. Global Viral Vaccines Sales Market Share by Type (2025-2030)

Table 54. Global Viral Vaccines Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Viral Vaccines Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Viral Vaccines Revenue Market Share by Type (2019-2024)

Table 57. Global Viral Vaccines Revenue Market Share by Type (2025-2030)

Table 58. Global Viral Vaccines Price (USD/MT) by Type (2019-2024)

Table 59. Global Viral Vaccines Price (USD/MT) by Type (2025-2030)

Table 60. Global Viral Vaccines Sales (K MT) by Application (2019-2024)

Table 61. Global Viral Vaccines Sales (K MT) by Application (2025-2030)

Table 62. Global Viral Vaccines Sales Market Share by Application (2019-2024)

Table 63. Global Viral Vaccines Sales Market Share by Application (2025-2030)

Table 64. Global Viral Vaccines Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Viral Vaccines Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Viral Vaccines Revenue Market Share by Application (2019-2024)

Table 67. Global Viral Vaccines Revenue Market Share by Application (2025-2030)

Table 68. Global Viral Vaccines Price (USD/MT) by Application (2019-2024)

Table 69. Global Viral Vaccines Price (USD/MT) by Application (2025-2030)

Table 70. GSK Corporation Information

Table 71. GSK Description and Business Overview

Table 72. GSK Viral Vaccines Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 73. GSK Viral Vaccines Product

Table 74. GSK Recent Developments/Updates

Table 75. Merck Corporation Information

Table 76. Merck Description and Business Overview

Table 77. Merck Viral Vaccines Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 78. Merck Viral Vaccines Product

Table 79. Merck Recent Developments/Updates

Table 80. Novartis Corporation Information

Table 81. Novartis Description and Business Overview

Table 82. Novartis Viral Vaccines Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 83. Novartis Viral Vaccines Product

Table 84. Novartis Recent Developments/Updates

Table 85. Pfizer Corporation Information

Table 86. Pfizer Description and Business Overview

Table 87. Pfizer Viral Vaccines Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 88. Pfizer Viral Vaccines Product

Table 89. Pfizer Recent Developments/Updates

Table 90. Sanofi Corporation Information

Table 91. Sanofi Description and Business Overview

Table 92. Sanofi Viral Vaccines Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 93. Sanofi Viral Vaccines Product

Table 94. Sanofi Recent Developments/Updates

Table 95. Bayer Corporation Information

Table 96. Bayer Description and Business Overview

Table 97. Bayer Viral Vaccines Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 98. Bayer Viral Vaccines Product

Table 99. Bayer Recent Developments/Updates

Table 100. Zoetis Corporation Information

Table 101. Zoetis Description and Business Overview

Table 102. Zoetis Viral Vaccines Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 103. Zoetis Viral Vaccines Product

Table 104. Zoetis Recent Developments/Updates

Table 105. AstraZeneca Corporation Information

Table 106. AstraZeneca Description and Business Overview

Table 107. AstraZeneca Viral Vaccines Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 108. AstraZeneca Viral Vaccines Product

Table 109. AstraZeneca Recent Developments/Updates

Table 110. Johnson Corporation Information

Table 111. Johnson Description and Business Overview

Table 112. Johnson Viral Vaccines Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 113. Johnson Viral Vaccines Product

Table 114. Johnson Recent Developments/Updates

Table 115. CSL Corporation Information

Table 116. CSL Description and Business Overview

Table 117. CSL Viral Vaccines Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 118. CSL Viral Vaccines Product

Table 119. CSL Recent Developments/Updates

Table 120. Key Raw Materials Lists

Table 121. Raw Materials Key Suppliers Lists

Table 122. Viral Vaccines Distributors List

Table 123. Viral Vaccines Customers List

Table 124. Viral Vaccines Market Trends

Table 125. Viral Vaccines Market Drivers

Table 126. Viral Vaccines Market Challenges

Table 127. Viral Vaccines Market Restraints

Table 128. Research Programs/Design for This Report

Table 129. Key Data Information from Secondary Sources

Table 130. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Viral Vaccines

Figure 2. Global Viral Vaccines Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Viral Vaccines Market Share by Type in 2023 & 2030

Figure 4. Attenuated Vaccine Product Picture

Figure 5. Inactivated Vaccine Product Picture

Figure 6. Global Viral Vaccines Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 7. Global Viral Vaccines Market Share by Application in 2023 & 2030

Figure 8. Hospital

Figure 9. Pharmaceutical Factory

Figure 10. Research Institute

Figure 11. Others

Figure 12. Global Viral Vaccines Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 13. Global Viral Vaccines Market Size (2019-2030) & (US$ Million)

Figure 14. Global Viral Vaccines Sales (2019-2030) & (K MT)

Figure 15. Global Viral Vaccines Average Price (USD/MT) & (2019-2030)

Figure 16. Viral Vaccines Report Years Considered

Figure 17. Viral Vaccines Sales Share by Manufacturers in 2023

Figure 18. Global Viral Vaccines Revenue Share by Manufacturers in 2023

Figure 19. The Global 5 and 10 Largest Viral Vaccines Players: Market Share by Revenue in 2023

Figure 20. Viral Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 21. Global Viral Vaccines Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 22. North America Viral Vaccines Sales Market Share by Country (2019-2030)

Figure 23. North America Viral Vaccines Revenue Market Share by Country (2019-2030)

Figure 24. U.S. Viral Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 25. Canada Viral Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 26. Europe Viral Vaccines Sales Market Share by Country (2019-2030)

Figure 27. Europe Viral Vaccines Revenue Market Share by Country (2019-2030)

Figure 28. Germany Viral Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 29. France Viral Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. U.K. Viral Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. Italy Viral Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. Russia Viral Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 33. Asia Pacific Viral Vaccines Sales Market Share by Region (2019-2030)

Figure 34. Asia Pacific Viral Vaccines Revenue Market Share by Region (2019-2030)

Figure 35. China Viral Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. Japan Viral Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. South Korea Viral Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. India Viral Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. Australia Viral Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. Taiwan Viral Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. Indonesia Viral Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. Thailand Viral Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Malaysia Viral Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Philippines Viral Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Latin America Viral Vaccines Sales Market Share by Country (2019-2030)

Figure 46. Latin America Viral Vaccines Revenue Market Share by Country (2019-2030)

Figure 47. Mexico Viral Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 48. Brazil Viral Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 49. Argentina Viral Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 50. Middle East & Africa Viral Vaccines Sales Market Share by Country (2019-2030)

Figure 51. Middle East & Africa Viral Vaccines Revenue Market Share by Country (2019-2030)

Figure 52. Turkey Viral Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 53. Saudi Arabia Viral Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 54. UAE Viral Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 55. Global Sales Market Share of Viral Vaccines by Type (2019-2030)

Figure 56. Global Revenue Market Share of Viral Vaccines by Type (2019-2030)

Figure 57. Global Viral Vaccines Price (USD/MT) by Type (2019-2030)

Figure 58. Global Sales Market Share of Viral Vaccines by Application (2019-2030)

Figure 59. Global Revenue Market Share of Viral Vaccines by Application (2019-2030)

Figure 60. Global Viral Vaccines Price (USD/MT) by Application (2019-2030)

Figure 61. Viral Vaccines Value Chain

Figure 62. Viral Vaccines Production Process

Figure 63. Channels of Distribution (Direct Vs Distribution)

Figure 64. Distributors Profiles

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

Figure 67. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions